MedPath

CHARLES COX

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Stem Cell Study for Long COVID-19 Neurological Symptoms

Phase 1
Not yet recruiting
Conditions
Post-Acute COVID-19 Syndrome
Interventions
Biological: Stem Cell
First Posted Date
2023-12-05
Last Posted Date
2023-12-05
Lead Sponsor
Charles Cox
Target Recruit Count
12
Registration Number
NCT06156241
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

ACT for CP Individual Patient Expanded Access IND Protocol

Conditions
Cerebral Palsy
First Posted Date
2017-06-29
Last Posted Date
2020-05-13
Lead Sponsor
Charles Cox
Registration Number
NCT03203941
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury

Phase 1
Withdrawn
Conditions
Traumatic Brain Injury
First Posted Date
2010-12-01
Last Posted Date
2015-12-10
Lead Sponsor
Charles Cox
Registration Number
NCT01251003
Locations
🇺🇸

The University of Texas Medical School at Houston, Children's Memorial Hermann Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath